Pharma & Healthcare
Global Human Rabies Immunoglobulin (IM) Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
- Jun 12, 25
- ID: 307385
- Pages: 152
- Figures: 150
- Views: 1
In 2024, the global market size of Human Rabies Immunoglobulin (IM) was estimated to be worth US$ 327 million and is forecast to reach approximately US$ 407 million by 2031 with a CAGR of 3.2% during the forecast period 2025-2031.
Rabies immunoglobulin (RIG) is a medication made up of antibodies against the rabies virus. It is used to prevent rabies following exposure. Human Rabies Immunoglobulin (IM) is rabies immunoglobulin antibody by the high price of healthy human plasma protein low temperature ethanol separation or other separation methods approved separation and purification, and by virus removal and inactivation treatment is made. Mainly used for rabies or other crazy animal bites, scratches patient's passive immunization. In this report, we study ERIG (Equine Rabies Immunoglobulin) and HRIG (Human Rabies Immunoglobulin)
The rising incidence of rabies, especially in developing countries, is a key driver of the human rabies immunoglobulin market. Rabies remains a significant public health concern, particularly in regions where animal vaccination programs are insufficient. Post-exposure prophylaxis (PEP), which includes human rabies immunoglobulin, is critical for preventing the virus after a bite from a rabid animal. Increasing awareness of rabies prevention, government initiatives, and partnerships with international health organizations have boosted demand for human rabies immunoglobulin in both rural and urban areas.
A major challenge in the human rabies immunoglobulin market is its limited availability and high cost, particularly in low- and middle-income countries where rabies is most prevalent. The production of immunoglobulins requires advanced technology and biological materials, making it costly and sometimes scarce in regions with insufficient healthcare infrastructure. Additionally, the need for timely administration after exposure poses logistical difficulties, especially in remote areas, where access to healthcare facilities may be delayed, potentially limiting the effectiveness of the treatment.
Asia-Pacific is expected to experience the highest growth in the market during the forecast period.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Human Rabies Immunoglobulin (IM), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Human Rabies Immunoglobulin (IM).
The Human Rabies Immunoglobulin (IM) market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Human Rabies Immunoglobulin (IM) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Human Rabies Immunoglobulin (IM) manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and regions.
By Company
CSL Behring
Grifols
Sanofi
Sichuan Yuanda Shuyang
Tiantan Bio
Kamada
CBPO
Shuanglin Bio
Weiguang Bio
Shanghai RAAS
Bharat Serum
VINS
Segment by Type
ERIG
HRIG
Segment by Application
Category II Exposure
Category III Exposure
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
Rest of Asia-Pacific
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Human Rabies Immunoglobulin (IM) in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 3: Detailed analysis of Human Rabies Immunoglobulin (IM) manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Human Rabies Immunoglobulin (IM) sales, revenue, price, gross margin, sales by region, by Type, by Application, and recent development, etc.
Chapter 5: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: APAC by Type, by Application and by country, sales, and revenue for each segment.
Chapter 9: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 10: Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Middle East and Africa by Type, by Application and by country, sales, and revenue for each segment.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: Research Findings and Conclusion.
Rabies immunoglobulin (RIG) is a medication made up of antibodies against the rabies virus. It is used to prevent rabies following exposure. Human Rabies Immunoglobulin (IM) is rabies immunoglobulin antibody by the high price of healthy human plasma protein low temperature ethanol separation or other separation methods approved separation and purification, and by virus removal and inactivation treatment is made. Mainly used for rabies or other crazy animal bites, scratches patient's passive immunization. In this report, we study ERIG (Equine Rabies Immunoglobulin) and HRIG (Human Rabies Immunoglobulin)
The rising incidence of rabies, especially in developing countries, is a key driver of the human rabies immunoglobulin market. Rabies remains a significant public health concern, particularly in regions where animal vaccination programs are insufficient. Post-exposure prophylaxis (PEP), which includes human rabies immunoglobulin, is critical for preventing the virus after a bite from a rabid animal. Increasing awareness of rabies prevention, government initiatives, and partnerships with international health organizations have boosted demand for human rabies immunoglobulin in both rural and urban areas.
A major challenge in the human rabies immunoglobulin market is its limited availability and high cost, particularly in low- and middle-income countries where rabies is most prevalent. The production of immunoglobulins requires advanced technology and biological materials, making it costly and sometimes scarce in regions with insufficient healthcare infrastructure. Additionally, the need for timely administration after exposure poses logistical difficulties, especially in remote areas, where access to healthcare facilities may be delayed, potentially limiting the effectiveness of the treatment.
Asia-Pacific is expected to experience the highest growth in the market during the forecast period.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Human Rabies Immunoglobulin (IM), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Human Rabies Immunoglobulin (IM).
The Human Rabies Immunoglobulin (IM) market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Human Rabies Immunoglobulin (IM) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Human Rabies Immunoglobulin (IM) manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and regions.
By Company
CSL Behring
Grifols
Sanofi
Sichuan Yuanda Shuyang
Tiantan Bio
Kamada
CBPO
Shuanglin Bio
Weiguang Bio
Shanghai RAAS
Bharat Serum
VINS
Segment by Type
ERIG
HRIG
Segment by Application
Category II Exposure
Category III Exposure
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
Rest of Asia-Pacific
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Human Rabies Immunoglobulin (IM) in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 3: Detailed analysis of Human Rabies Immunoglobulin (IM) manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Human Rabies Immunoglobulin (IM) sales, revenue, price, gross margin, sales by region, by Type, by Application, and recent development, etc.
Chapter 5: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: APAC by Type, by Application and by country, sales, and revenue for each segment.
Chapter 9: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 10: Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Middle East and Africa by Type, by Application and by country, sales, and revenue for each segment.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: Research Findings and Conclusion.
1 Study Coverage
1.1 Human Rabies Immunoglobulin (IM) Product Introduction
1.2 Market by Type
1.2.1 Global Human Rabies Immunoglobulin (IM) Market Size Growth Rate by Type (2020 VS 2024 VS 2031)
1.2.2 ERIG
1.2.3 HRIG
1.3 Market by Application
1.3.1 Global Human Rabies Immunoglobulin (IM) Market Size Growth Rate by Application (2020 VS 2024 VS 2031)
1.3.2 Category II Exposure
1.3.3 Category III Exposure
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Human Rabies Immunoglobulin (IM) Market Size Estimates and Forecasts
2.1.1 Global Human Rabies Immunoglobulin (IM) Revenue 2020-2031
2.1.2 Global Human Rabies Immunoglobulin (IM) Sales 2020-2031
2.2 Human Rabies Immunoglobulin (IM) Market Size by Region: 2024 Versus 2031
2.3 Human Rabies Immunoglobulin (IM) Sales by Region (2020-2031)
2.3.1 Global Human Rabies Immunoglobulin (IM) Sales by Region: 2020-2025
2.3.2 Global Human Rabies Immunoglobulin (IM) Sales Forecast by Region (2026-2031)
2.3.3 Global Human Rabies Immunoglobulin (IM) Sales Market Share by Region (2020-2031)
2.4 Human Rabies Immunoglobulin (IM) Market Estimates and Projections by Region (2026-2031)
2.4.1 Global Human Rabies Immunoglobulin (IM) Revenue by Region: 2020-2025
2.4.2 Global Human Rabies Immunoglobulin (IM) Revenue Forecast by Region (2026-2031)
2.4.3 Global Human Rabies Immunoglobulin (IM) Revenue Market Share by Region (2020-2031)
3 Market Segments
3.1 Breakdown Data by Type
3.1.1 Global Human Rabies Immunoglobulin (IM) Sales by Type (2020-2031)
3.1.1.1 Global Human Rabies Immunoglobulin (IM) Sales Volume by Type (2020-2031)
3.1.1.2 Global Human Rabies Immunoglobulin (IM) Sales Market Share by Type (2020-2031)
3.1.2 Global Human Rabies Immunoglobulin (IM) Revenue by Type (2020-2031)
3.1.2.1 Global Human Rabies Immunoglobulin (IM) Revenue by Type (2020-2031)
3.1.2.2 Global Human Rabies Immunoglobulin (IM) Revenue Market Share by Type (2020-2031)
3.1.3 Human Rabies Immunoglobulin (IM) Average Selling Price (ASP) by Type (2020-2031)
3.2 Breakdown Data by Application
3.2.1 Global Human Rabies Immunoglobulin (IM) Sales by Application (2020-2031)
3.2.1.1 Global Human Rabies Immunoglobulin (IM) Sales Volume by Application (2020-2031)
3.2.1.2 Global Human Rabies Immunoglobulin (IM) Sales Market Share by Application (2020-2031)
3.2.2 Global Human Rabies Immunoglobulin (IM) Revenue by Application (2020-2031)
3.2.2.1 Global Human Rabies Immunoglobulin (IM) Revenue by Application (2020-2031)
3.2.2.2 Global Human Rabies Immunoglobulin (IM) Revenue Market Share by Application (2020-2031)
3.2.3 Human Rabies Immunoglobulin (IM) Average Selling Price (ASP) by Application (2020-2031)
3.3 by Type and by Application Crossing Analysis
3.3.1 ERIG of Human Rabies Immunoglobulin (IM) Revenue Market Share by Application
3.3.2 HRIG of Human Rabies Immunoglobulin (IM) Revenue Market Share by Application
4 Global Human Rabies Immunoglobulin (IM) by Manufacturers
4.1 Global Top Human Rabies Immunoglobulin (IM) Manufacturers by Sales (2020-2025)
4.1.1 Global Human Rabies Immunoglobulin (IM) Sales by Manufacturer (2020-2025)
4.1.2 Global Human Rabies Immunoglobulin (IM) Sales Market Share by Manufacturer (2020-2025)
4.2 Global Top Human Rabies Immunoglobulin (IM) Manufacturers by Revenue (2020-2025)
4.2.1 Global Human Rabies Immunoglobulin (IM) Revenue by Manufacturer (2020-2025)
4.2.2 Global Human Rabies Immunoglobulin (IM) Revenue Share by Manufacturer (2020-2025)
4.3 Global Human Rabies Immunoglobulin (IM) Price by Manufacturer (2020-2025)
4.4 Competitive Landscape
4.4.1 Key Human Rabies Immunoglobulin (IM) Manufacturers Covered: Ranking by Revenue
4.4.2 Global Human Rabies Immunoglobulin (IM) Market Concentration Ratio (CR5 and HHI) & (2020-2025)
4.4.3 Global Human Rabies Immunoglobulin (IM) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.5 Global Human Rabies Immunoglobulin (IM) Manufacturing Base Distribution, Product Type
4.5.1 Human Rabies Immunoglobulin (IM) Manufacturers Manufacturing Base Distribution, Headquarters
4.5.2 Date of International Manufacturers Enter into Human Rabies Immunoglobulin (IM) Market
4.5.3 Manufacturers Human Rabies Immunoglobulin (IM) Product Type and Application
4.5.4 ERIG Market Sales of Human Rabies Immunoglobulin (IM) by Manufacturer
4.5.5 HRIG Market Sales of Human Rabies Immunoglobulin (IM) by Manufacturer
4.6 Manufacturers Mergers & Acquisitions, Expansion Plans
5 Company Profiles
5.1 CSL Behring
5.1.1 CSL Behring Company Information
5.1.2 CSL Behring Description, Business Overview
5.1.3 CSL Behring Human Rabies Immunoglobulin (IM) Products Offered
5.1.4 CSL Behring Human Rabies Immunoglobulin (IM) Sales, Revenue and Gross Margin (2020-2025)
5.1.5 CSL Behring Human Rabies Immunoglobulin (IM) Sales by Product in 2024
5.1.6 CSL Behring Human Rabies Immunoglobulin (IM) Sales by Application in 2024
5.1.7 CSL Behring Human Rabies Immunoglobulin (IM) Sales by Geographic Area in 2024
5.1.8 CSL Behring Recent Developments
5.2 Grifols
5.2.1 Grifols Company Information
5.2.2 Grifols Description, Business Overview
5.2.3 Grifols Human Rabies Immunoglobulin (IM) Products Offered
5.2.4 Grifols Human Rabies Immunoglobulin (IM) Sales, Revenue and Gross Margin (2020-2025)
5.2.5 Grifols Human Rabies Immunoglobulin (IM) Sales by Product in 2024
5.2.6 Grifols Human Rabies Immunoglobulin (IM) Sales by Application in 2024
5.2.7 Grifols Human Rabies Immunoglobulin (IM) Sales by Geographic Area in 2024
5.2.8 Grifols Recent Developments
5.3 Sanofi
5.3.1 Sanofi Company Information
5.3.2 Sanofi Description, Business Overview
5.3.3 Sanofi Human Rabies Immunoglobulin (IM) Products Offered
5.3.4 Sanofi Human Rabies Immunoglobulin (IM) Sales, Revenue and Gross Margin (2020-2025)
5.3.5 Sanofi Human Rabies Immunoglobulin (IM) Sales by Product in 2024
5.3.6 Sanofi Human Rabies Immunoglobulin (IM) Sales by Application in 2024
5.3.7 Sanofi Human Rabies Immunoglobulin (IM) Sales by Geographic Area in 2024
5.3.8 Sanofi Recent Developments
5.4 Sichuan Yuanda Shuyang
5.4.1 Sichuan Yuanda Shuyang Company Information
5.4.2 Sichuan Yuanda Shuyang Description, Business Overview
5.4.3 Sichuan Yuanda Shuyang Human Rabies Immunoglobulin (IM) Products Offered
5.4.4 Sichuan Yuanda Shuyang Human Rabies Immunoglobulin (IM) Sales, Revenue and Gross Margin (2020-2025)
5.4.5 Sichuan Yuanda Shuyang Human Rabies Immunoglobulin (IM) Sales by Product in 2024
5.4.6 Sichuan Yuanda Shuyang Human Rabies Immunoglobulin (IM) Sales by Application in 2024
5.4.7 Sichuan Yuanda Shuyang Human Rabies Immunoglobulin (IM) Sales by Geographic Area in 2024
5.4.8 Sichuan Yuanda Shuyang Recent Developments
5.5 Tiantan Bio
5.5.1 Tiantan Bio Company Information
5.5.2 Tiantan Bio Description, Business Overview
5.5.3 Tiantan Bio Human Rabies Immunoglobulin (IM) Products Offered
5.5.4 Tiantan Bio Human Rabies Immunoglobulin (IM) Sales, Revenue and Gross Margin (2020-2025)
5.5.5 Tiantan Bio Human Rabies Immunoglobulin (IM) Sales by Product in 2024
5.5.6 Tiantan Bio Human Rabies Immunoglobulin (IM) Sales by Application in 2024
5.5.7 Tiantan Bio Human Rabies Immunoglobulin (IM) Sales by Geographic Area in 2024
5.5.8 Tiantan Bio Recent Developments
5.6 Kamada
5.6.1 Kamada Company Information
5.6.2 Kamada Description, Business Overview
5.6.3 Kamada Human Rabies Immunoglobulin (IM) Products Offered
5.6.4 Kamada Human Rabies Immunoglobulin (IM) Sales, Revenue and Gross Margin (2020-2025)
5.6.5 Kamada Human Rabies Immunoglobulin (IM) Sales by Product in 2024
5.6.6 Kamada Human Rabies Immunoglobulin (IM) Sales by Application in 2024
5.6.7 Kamada Human Rabies Immunoglobulin (IM) Sales by Geographic Area in 2024
5.6.8 Kamada Recent Developments
5.7 CBPO
5.7.1 CBPO Company Information
5.7.2 CBPO Description, Business Overview
5.7.3 CBPO Human Rabies Immunoglobulin (IM) Products Offered
5.7.4 CBPO Human Rabies Immunoglobulin (IM) Sales, Revenue and Gross Margin (2020-2025)
5.7.5 CBPO Human Rabies Immunoglobulin (IM) Sales by Product in 2024
5.7.6 CBPO Human Rabies Immunoglobulin (IM) Sales by Application in 2024
5.7.7 CBPO Human Rabies Immunoglobulin (IM) Sales by Geographic Area in 2024
5.7.8 CBPO Recent Developments
5.8 Shuanglin Bio
5.8.1 Shuanglin Bio Company Information
5.8.2 Shuanglin Bio Description, Business Overview
5.8.3 Shuanglin Bio Human Rabies Immunoglobulin (IM) Products Offered
5.8.4 Shuanglin Bio Human Rabies Immunoglobulin (IM) Sales, Revenue and Gross Margin (2020-2025)
5.8.5 Shuanglin Bio Human Rabies Immunoglobulin (IM) Sales by Product in 2024
5.8.6 Shuanglin Bio Human Rabies Immunoglobulin (IM) Sales by Application in 2024
5.8.7 Shuanglin Bio Human Rabies Immunoglobulin (IM) Sales by Geographic Area in 2024
5.8.8 Shuanglin Bio Recent Developments
5.9 Weiguang Bio
5.9.1 Weiguang Bio Company Information
5.9.2 Weiguang Bio Description, Business Overview
5.9.3 Weiguang Bio Human Rabies Immunoglobulin (IM) Products Offered
5.9.4 Weiguang Bio Human Rabies Immunoglobulin (IM) Sales, Revenue and Gross Margin (2020-2025)
5.9.5 Weiguang Bio Human Rabies Immunoglobulin (IM) Sales by Product in 2024
5.9.6 Weiguang Bio Human Rabies Immunoglobulin (IM) Sales by Application in 2024
5.9.7 Weiguang Bio Human Rabies Immunoglobulin (IM) Sales by Geographic Area in 2024
5.9.8 Weiguang Bio Recent Developments
5.10 Shanghai RAAS
5.10.1 Shanghai RAAS Company Information
5.10.2 Shanghai RAAS Description, Business Overview
5.10.3 Shanghai RAAS Human Rabies Immunoglobulin (IM) Products Offered
5.10.4 Shanghai RAAS Human Rabies Immunoglobulin (IM) Sales, Revenue and Gross Margin (2020-2025)
5.10.5 Shanghai RAAS Human Rabies Immunoglobulin (IM) Sales by Product in 2024
5.10.6 Shanghai RAAS Human Rabies Immunoglobulin (IM) Sales by Application in 2024
5.10.7 Shanghai RAAS Human Rabies Immunoglobulin (IM) Sales by Geographic Area in 2024
5.10.8 Shanghai RAAS Recent Developments
5.11 Bharat Serum
5.11.1 Bharat Serum Company Information
5.11.2 Bharat Serum Description, Business Overview
5.11.3 Bharat Serum Human Rabies Immunoglobulin (IM) Products Offered
5.11.4 Bharat Serum Human Rabies Immunoglobulin (IM) Sales, Revenue and Gross Margin (2020-2025)
5.11.5 Bharat Serum Human Rabies Immunoglobulin (IM) Sales by Product in 2024
5.11.6 Bharat Serum Human Rabies Immunoglobulin (IM) Sales by Application in 2024
5.11.7 Bharat Serum Human Rabies Immunoglobulin (IM) Sales by Geographic Area in 2024
5.11.8 Bharat Serum Recent Developments
5.12 VINS
5.12.1 VINS Company Information
5.12.2 VINS Description, Business Overview
5.12.3 VINS Human Rabies Immunoglobulin (IM) Products Offered
5.12.4 VINS Human Rabies Immunoglobulin (IM) Sales, Revenue and Gross Margin (2020-2025)
5.12.5 VINS Human Rabies Immunoglobulin (IM) Sales by Product in 2024
5.12.6 VINS Human Rabies Immunoglobulin (IM) Sales by Application in 2024
5.12.7 VINS Human Rabies Immunoglobulin (IM) Sales by Geographic Area in 2024
5.12.8 VINS Recent Developments
6 North America
6.1 North America Human Rabies Immunoglobulin (IM) Market Size YoY Growth 2020-2031
6.2 North America Human Rabies Immunoglobulin (IM) Market Facts & Figures by Country
6.2.1 North America Human Rabies Immunoglobulin (IM) Sales by Country (2020-2031)
6.2.2 North America Human Rabies Immunoglobulin (IM) Revenue by Country (2020-2031)
6.3 North America Human Rabies Immunoglobulin (IM) Sales by Type (2020-2025)
6.4 North America Human Rabies Immunoglobulin (IM) Sales by Application (2020-2025)
7 Asia-Pacific
7.1 Asia-Pacific Human Rabies Immunoglobulin (IM) Market Size YoY Growth 2020-2031
7.2 Asia-Pacific Human Rabies Immunoglobulin (IM) Market Facts & Figures by Region
7.2.1 Asia-Pacific Human Rabies Immunoglobulin (IM) Sales by Region (2020-2031)
7.2.2 Asia-Pacific Human Rabies Immunoglobulin (IM) Revenue by Region (2020-2031)
7.3 Asia-Pacific Human Rabies Immunoglobulin (IM) Sales by Type (2020-2025)
7.4 Asia-Pacific Human Rabies Immunoglobulin (IM) Sales by Application (2020-2025)
8 Europe
8.1 Europe Human Rabies Immunoglobulin (IM) Market Size YoY Growth 2020-2031
8.2 Europe Human Rabies Immunoglobulin (IM) Market Facts & Figures by Country
8.2.1 Europe Human Rabies Immunoglobulin (IM) Sales by Country (2020-2031)
8.2.2 Europe Human Rabies Immunoglobulin (IM) Revenue by Country (2020-2031)
8.3 Europe Human Rabies Immunoglobulin (IM) Sales by Type (2020-2025)
8.4 Europe Human Rabies Immunoglobulin (IM) Sales by Application (2020-2025)
9 Latin America
9.1 Latin America Human Rabies Immunoglobulin (IM) Market Size YoY Growth 2020-2031
9.2 Latin America Human Rabies Immunoglobulin (IM) Market Facts & Figures by Country
9.2.1 Latin America Human Rabies Immunoglobulin (IM) Sales by Country (2020-2031)
9.2.2 Latin America Human Rabies Immunoglobulin (IM) Revenue by Country (2020-2031)
9.3 Latin America Human Rabies Immunoglobulin (IM) Sales by Type (2020-2025)
9.4 Latin America Human Rabies Immunoglobulin (IM) Sales by Application (2020-2025)
10 Middle East and Africa
10.1 Latin America Human Rabies Immunoglobulin (IM) Market Size YoY Growth 2020-2031
10.2 Middle East and Africa Human Rabies Immunoglobulin (IM) Market Facts & Figures by Country
10.2.1 Middle East and Africa Human Rabies Immunoglobulin (IM) Sales by Country (2020-2031)
10.2.2 Middle East and Africa Human Rabies Immunoglobulin (IM) Revenue by Country (2020-2031)
10.3 Middle East and Africa Human Rabies Immunoglobulin (IM) Sales by Type (2020-2025)
10.4 Middle East and Africa Human Rabies Immunoglobulin (IM) Sales by Application (2020-2025)
11 Supply Chain and Sales Channel analysis
11.1 Human Rabies Immunoglobulin (IM) Supply Chain Analysis
11.2 Human Rabies Immunoglobulin (IM) Key Raw Materials and Upstream Suppliers
11.3 Human Rabies Immunoglobulin (IM) Clients Analysis
11.4 Human Rabies Immunoglobulin (IM) Sales Channel and Sales Model Analysis
11.4.1 Human Rabies Immunoglobulin (IM) Distribution Channel Analysis: Indirect Sales VS Direct Sales
11.4.2 Human Rabies Immunoglobulin (IM) Distribution Channel Analysis: Online Sales VS Offline Sales
11.4.3 Human Rabies Immunoglobulin (IM) Distributors
12 Human Rabies Immunoglobulin (IM) Market Dynamics
12.1 Human Rabies Immunoglobulin (IM) Industry Trends
12.2 Human Rabies Immunoglobulin (IM) Market Drivers
12.3 Human Rabies Immunoglobulin (IM) Market Challenges
12.4 Human Rabies Immunoglobulin (IM) Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
1.1 Human Rabies Immunoglobulin (IM) Product Introduction
1.2 Market by Type
1.2.1 Global Human Rabies Immunoglobulin (IM) Market Size Growth Rate by Type (2020 VS 2024 VS 2031)
1.2.2 ERIG
1.2.3 HRIG
1.3 Market by Application
1.3.1 Global Human Rabies Immunoglobulin (IM) Market Size Growth Rate by Application (2020 VS 2024 VS 2031)
1.3.2 Category II Exposure
1.3.3 Category III Exposure
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Human Rabies Immunoglobulin (IM) Market Size Estimates and Forecasts
2.1.1 Global Human Rabies Immunoglobulin (IM) Revenue 2020-2031
2.1.2 Global Human Rabies Immunoglobulin (IM) Sales 2020-2031
2.2 Human Rabies Immunoglobulin (IM) Market Size by Region: 2024 Versus 2031
2.3 Human Rabies Immunoglobulin (IM) Sales by Region (2020-2031)
2.3.1 Global Human Rabies Immunoglobulin (IM) Sales by Region: 2020-2025
2.3.2 Global Human Rabies Immunoglobulin (IM) Sales Forecast by Region (2026-2031)
2.3.3 Global Human Rabies Immunoglobulin (IM) Sales Market Share by Region (2020-2031)
2.4 Human Rabies Immunoglobulin (IM) Market Estimates and Projections by Region (2026-2031)
2.4.1 Global Human Rabies Immunoglobulin (IM) Revenue by Region: 2020-2025
2.4.2 Global Human Rabies Immunoglobulin (IM) Revenue Forecast by Region (2026-2031)
2.4.3 Global Human Rabies Immunoglobulin (IM) Revenue Market Share by Region (2020-2031)
3 Market Segments
3.1 Breakdown Data by Type
3.1.1 Global Human Rabies Immunoglobulin (IM) Sales by Type (2020-2031)
3.1.1.1 Global Human Rabies Immunoglobulin (IM) Sales Volume by Type (2020-2031)
3.1.1.2 Global Human Rabies Immunoglobulin (IM) Sales Market Share by Type (2020-2031)
3.1.2 Global Human Rabies Immunoglobulin (IM) Revenue by Type (2020-2031)
3.1.2.1 Global Human Rabies Immunoglobulin (IM) Revenue by Type (2020-2031)
3.1.2.2 Global Human Rabies Immunoglobulin (IM) Revenue Market Share by Type (2020-2031)
3.1.3 Human Rabies Immunoglobulin (IM) Average Selling Price (ASP) by Type (2020-2031)
3.2 Breakdown Data by Application
3.2.1 Global Human Rabies Immunoglobulin (IM) Sales by Application (2020-2031)
3.2.1.1 Global Human Rabies Immunoglobulin (IM) Sales Volume by Application (2020-2031)
3.2.1.2 Global Human Rabies Immunoglobulin (IM) Sales Market Share by Application (2020-2031)
3.2.2 Global Human Rabies Immunoglobulin (IM) Revenue by Application (2020-2031)
3.2.2.1 Global Human Rabies Immunoglobulin (IM) Revenue by Application (2020-2031)
3.2.2.2 Global Human Rabies Immunoglobulin (IM) Revenue Market Share by Application (2020-2031)
3.2.3 Human Rabies Immunoglobulin (IM) Average Selling Price (ASP) by Application (2020-2031)
3.3 by Type and by Application Crossing Analysis
3.3.1 ERIG of Human Rabies Immunoglobulin (IM) Revenue Market Share by Application
3.3.2 HRIG of Human Rabies Immunoglobulin (IM) Revenue Market Share by Application
4 Global Human Rabies Immunoglobulin (IM) by Manufacturers
4.1 Global Top Human Rabies Immunoglobulin (IM) Manufacturers by Sales (2020-2025)
4.1.1 Global Human Rabies Immunoglobulin (IM) Sales by Manufacturer (2020-2025)
4.1.2 Global Human Rabies Immunoglobulin (IM) Sales Market Share by Manufacturer (2020-2025)
4.2 Global Top Human Rabies Immunoglobulin (IM) Manufacturers by Revenue (2020-2025)
4.2.1 Global Human Rabies Immunoglobulin (IM) Revenue by Manufacturer (2020-2025)
4.2.2 Global Human Rabies Immunoglobulin (IM) Revenue Share by Manufacturer (2020-2025)
4.3 Global Human Rabies Immunoglobulin (IM) Price by Manufacturer (2020-2025)
4.4 Competitive Landscape
4.4.1 Key Human Rabies Immunoglobulin (IM) Manufacturers Covered: Ranking by Revenue
4.4.2 Global Human Rabies Immunoglobulin (IM) Market Concentration Ratio (CR5 and HHI) & (2020-2025)
4.4.3 Global Human Rabies Immunoglobulin (IM) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.5 Global Human Rabies Immunoglobulin (IM) Manufacturing Base Distribution, Product Type
4.5.1 Human Rabies Immunoglobulin (IM) Manufacturers Manufacturing Base Distribution, Headquarters
4.5.2 Date of International Manufacturers Enter into Human Rabies Immunoglobulin (IM) Market
4.5.3 Manufacturers Human Rabies Immunoglobulin (IM) Product Type and Application
4.5.4 ERIG Market Sales of Human Rabies Immunoglobulin (IM) by Manufacturer
4.5.5 HRIG Market Sales of Human Rabies Immunoglobulin (IM) by Manufacturer
4.6 Manufacturers Mergers & Acquisitions, Expansion Plans
5 Company Profiles
5.1 CSL Behring
5.1.1 CSL Behring Company Information
5.1.2 CSL Behring Description, Business Overview
5.1.3 CSL Behring Human Rabies Immunoglobulin (IM) Products Offered
5.1.4 CSL Behring Human Rabies Immunoglobulin (IM) Sales, Revenue and Gross Margin (2020-2025)
5.1.5 CSL Behring Human Rabies Immunoglobulin (IM) Sales by Product in 2024
5.1.6 CSL Behring Human Rabies Immunoglobulin (IM) Sales by Application in 2024
5.1.7 CSL Behring Human Rabies Immunoglobulin (IM) Sales by Geographic Area in 2024
5.1.8 CSL Behring Recent Developments
5.2 Grifols
5.2.1 Grifols Company Information
5.2.2 Grifols Description, Business Overview
5.2.3 Grifols Human Rabies Immunoglobulin (IM) Products Offered
5.2.4 Grifols Human Rabies Immunoglobulin (IM) Sales, Revenue and Gross Margin (2020-2025)
5.2.5 Grifols Human Rabies Immunoglobulin (IM) Sales by Product in 2024
5.2.6 Grifols Human Rabies Immunoglobulin (IM) Sales by Application in 2024
5.2.7 Grifols Human Rabies Immunoglobulin (IM) Sales by Geographic Area in 2024
5.2.8 Grifols Recent Developments
5.3 Sanofi
5.3.1 Sanofi Company Information
5.3.2 Sanofi Description, Business Overview
5.3.3 Sanofi Human Rabies Immunoglobulin (IM) Products Offered
5.3.4 Sanofi Human Rabies Immunoglobulin (IM) Sales, Revenue and Gross Margin (2020-2025)
5.3.5 Sanofi Human Rabies Immunoglobulin (IM) Sales by Product in 2024
5.3.6 Sanofi Human Rabies Immunoglobulin (IM) Sales by Application in 2024
5.3.7 Sanofi Human Rabies Immunoglobulin (IM) Sales by Geographic Area in 2024
5.3.8 Sanofi Recent Developments
5.4 Sichuan Yuanda Shuyang
5.4.1 Sichuan Yuanda Shuyang Company Information
5.4.2 Sichuan Yuanda Shuyang Description, Business Overview
5.4.3 Sichuan Yuanda Shuyang Human Rabies Immunoglobulin (IM) Products Offered
5.4.4 Sichuan Yuanda Shuyang Human Rabies Immunoglobulin (IM) Sales, Revenue and Gross Margin (2020-2025)
5.4.5 Sichuan Yuanda Shuyang Human Rabies Immunoglobulin (IM) Sales by Product in 2024
5.4.6 Sichuan Yuanda Shuyang Human Rabies Immunoglobulin (IM) Sales by Application in 2024
5.4.7 Sichuan Yuanda Shuyang Human Rabies Immunoglobulin (IM) Sales by Geographic Area in 2024
5.4.8 Sichuan Yuanda Shuyang Recent Developments
5.5 Tiantan Bio
5.5.1 Tiantan Bio Company Information
5.5.2 Tiantan Bio Description, Business Overview
5.5.3 Tiantan Bio Human Rabies Immunoglobulin (IM) Products Offered
5.5.4 Tiantan Bio Human Rabies Immunoglobulin (IM) Sales, Revenue and Gross Margin (2020-2025)
5.5.5 Tiantan Bio Human Rabies Immunoglobulin (IM) Sales by Product in 2024
5.5.6 Tiantan Bio Human Rabies Immunoglobulin (IM) Sales by Application in 2024
5.5.7 Tiantan Bio Human Rabies Immunoglobulin (IM) Sales by Geographic Area in 2024
5.5.8 Tiantan Bio Recent Developments
5.6 Kamada
5.6.1 Kamada Company Information
5.6.2 Kamada Description, Business Overview
5.6.3 Kamada Human Rabies Immunoglobulin (IM) Products Offered
5.6.4 Kamada Human Rabies Immunoglobulin (IM) Sales, Revenue and Gross Margin (2020-2025)
5.6.5 Kamada Human Rabies Immunoglobulin (IM) Sales by Product in 2024
5.6.6 Kamada Human Rabies Immunoglobulin (IM) Sales by Application in 2024
5.6.7 Kamada Human Rabies Immunoglobulin (IM) Sales by Geographic Area in 2024
5.6.8 Kamada Recent Developments
5.7 CBPO
5.7.1 CBPO Company Information
5.7.2 CBPO Description, Business Overview
5.7.3 CBPO Human Rabies Immunoglobulin (IM) Products Offered
5.7.4 CBPO Human Rabies Immunoglobulin (IM) Sales, Revenue and Gross Margin (2020-2025)
5.7.5 CBPO Human Rabies Immunoglobulin (IM) Sales by Product in 2024
5.7.6 CBPO Human Rabies Immunoglobulin (IM) Sales by Application in 2024
5.7.7 CBPO Human Rabies Immunoglobulin (IM) Sales by Geographic Area in 2024
5.7.8 CBPO Recent Developments
5.8 Shuanglin Bio
5.8.1 Shuanglin Bio Company Information
5.8.2 Shuanglin Bio Description, Business Overview
5.8.3 Shuanglin Bio Human Rabies Immunoglobulin (IM) Products Offered
5.8.4 Shuanglin Bio Human Rabies Immunoglobulin (IM) Sales, Revenue and Gross Margin (2020-2025)
5.8.5 Shuanglin Bio Human Rabies Immunoglobulin (IM) Sales by Product in 2024
5.8.6 Shuanglin Bio Human Rabies Immunoglobulin (IM) Sales by Application in 2024
5.8.7 Shuanglin Bio Human Rabies Immunoglobulin (IM) Sales by Geographic Area in 2024
5.8.8 Shuanglin Bio Recent Developments
5.9 Weiguang Bio
5.9.1 Weiguang Bio Company Information
5.9.2 Weiguang Bio Description, Business Overview
5.9.3 Weiguang Bio Human Rabies Immunoglobulin (IM) Products Offered
5.9.4 Weiguang Bio Human Rabies Immunoglobulin (IM) Sales, Revenue and Gross Margin (2020-2025)
5.9.5 Weiguang Bio Human Rabies Immunoglobulin (IM) Sales by Product in 2024
5.9.6 Weiguang Bio Human Rabies Immunoglobulin (IM) Sales by Application in 2024
5.9.7 Weiguang Bio Human Rabies Immunoglobulin (IM) Sales by Geographic Area in 2024
5.9.8 Weiguang Bio Recent Developments
5.10 Shanghai RAAS
5.10.1 Shanghai RAAS Company Information
5.10.2 Shanghai RAAS Description, Business Overview
5.10.3 Shanghai RAAS Human Rabies Immunoglobulin (IM) Products Offered
5.10.4 Shanghai RAAS Human Rabies Immunoglobulin (IM) Sales, Revenue and Gross Margin (2020-2025)
5.10.5 Shanghai RAAS Human Rabies Immunoglobulin (IM) Sales by Product in 2024
5.10.6 Shanghai RAAS Human Rabies Immunoglobulin (IM) Sales by Application in 2024
5.10.7 Shanghai RAAS Human Rabies Immunoglobulin (IM) Sales by Geographic Area in 2024
5.10.8 Shanghai RAAS Recent Developments
5.11 Bharat Serum
5.11.1 Bharat Serum Company Information
5.11.2 Bharat Serum Description, Business Overview
5.11.3 Bharat Serum Human Rabies Immunoglobulin (IM) Products Offered
5.11.4 Bharat Serum Human Rabies Immunoglobulin (IM) Sales, Revenue and Gross Margin (2020-2025)
5.11.5 Bharat Serum Human Rabies Immunoglobulin (IM) Sales by Product in 2024
5.11.6 Bharat Serum Human Rabies Immunoglobulin (IM) Sales by Application in 2024
5.11.7 Bharat Serum Human Rabies Immunoglobulin (IM) Sales by Geographic Area in 2024
5.11.8 Bharat Serum Recent Developments
5.12 VINS
5.12.1 VINS Company Information
5.12.2 VINS Description, Business Overview
5.12.3 VINS Human Rabies Immunoglobulin (IM) Products Offered
5.12.4 VINS Human Rabies Immunoglobulin (IM) Sales, Revenue and Gross Margin (2020-2025)
5.12.5 VINS Human Rabies Immunoglobulin (IM) Sales by Product in 2024
5.12.6 VINS Human Rabies Immunoglobulin (IM) Sales by Application in 2024
5.12.7 VINS Human Rabies Immunoglobulin (IM) Sales by Geographic Area in 2024
5.12.8 VINS Recent Developments
6 North America
6.1 North America Human Rabies Immunoglobulin (IM) Market Size YoY Growth 2020-2031
6.2 North America Human Rabies Immunoglobulin (IM) Market Facts & Figures by Country
6.2.1 North America Human Rabies Immunoglobulin (IM) Sales by Country (2020-2031)
6.2.2 North America Human Rabies Immunoglobulin (IM) Revenue by Country (2020-2031)
6.3 North America Human Rabies Immunoglobulin (IM) Sales by Type (2020-2025)
6.4 North America Human Rabies Immunoglobulin (IM) Sales by Application (2020-2025)
7 Asia-Pacific
7.1 Asia-Pacific Human Rabies Immunoglobulin (IM) Market Size YoY Growth 2020-2031
7.2 Asia-Pacific Human Rabies Immunoglobulin (IM) Market Facts & Figures by Region
7.2.1 Asia-Pacific Human Rabies Immunoglobulin (IM) Sales by Region (2020-2031)
7.2.2 Asia-Pacific Human Rabies Immunoglobulin (IM) Revenue by Region (2020-2031)
7.3 Asia-Pacific Human Rabies Immunoglobulin (IM) Sales by Type (2020-2025)
7.4 Asia-Pacific Human Rabies Immunoglobulin (IM) Sales by Application (2020-2025)
8 Europe
8.1 Europe Human Rabies Immunoglobulin (IM) Market Size YoY Growth 2020-2031
8.2 Europe Human Rabies Immunoglobulin (IM) Market Facts & Figures by Country
8.2.1 Europe Human Rabies Immunoglobulin (IM) Sales by Country (2020-2031)
8.2.2 Europe Human Rabies Immunoglobulin (IM) Revenue by Country (2020-2031)
8.3 Europe Human Rabies Immunoglobulin (IM) Sales by Type (2020-2025)
8.4 Europe Human Rabies Immunoglobulin (IM) Sales by Application (2020-2025)
9 Latin America
9.1 Latin America Human Rabies Immunoglobulin (IM) Market Size YoY Growth 2020-2031
9.2 Latin America Human Rabies Immunoglobulin (IM) Market Facts & Figures by Country
9.2.1 Latin America Human Rabies Immunoglobulin (IM) Sales by Country (2020-2031)
9.2.2 Latin America Human Rabies Immunoglobulin (IM) Revenue by Country (2020-2031)
9.3 Latin America Human Rabies Immunoglobulin (IM) Sales by Type (2020-2025)
9.4 Latin America Human Rabies Immunoglobulin (IM) Sales by Application (2020-2025)
10 Middle East and Africa
10.1 Latin America Human Rabies Immunoglobulin (IM) Market Size YoY Growth 2020-2031
10.2 Middle East and Africa Human Rabies Immunoglobulin (IM) Market Facts & Figures by Country
10.2.1 Middle East and Africa Human Rabies Immunoglobulin (IM) Sales by Country (2020-2031)
10.2.2 Middle East and Africa Human Rabies Immunoglobulin (IM) Revenue by Country (2020-2031)
10.3 Middle East and Africa Human Rabies Immunoglobulin (IM) Sales by Type (2020-2025)
10.4 Middle East and Africa Human Rabies Immunoglobulin (IM) Sales by Application (2020-2025)
11 Supply Chain and Sales Channel analysis
11.1 Human Rabies Immunoglobulin (IM) Supply Chain Analysis
11.2 Human Rabies Immunoglobulin (IM) Key Raw Materials and Upstream Suppliers
11.3 Human Rabies Immunoglobulin (IM) Clients Analysis
11.4 Human Rabies Immunoglobulin (IM) Sales Channel and Sales Model Analysis
11.4.1 Human Rabies Immunoglobulin (IM) Distribution Channel Analysis: Indirect Sales VS Direct Sales
11.4.2 Human Rabies Immunoglobulin (IM) Distribution Channel Analysis: Online Sales VS Offline Sales
11.4.3 Human Rabies Immunoglobulin (IM) Distributors
12 Human Rabies Immunoglobulin (IM) Market Dynamics
12.1 Human Rabies Immunoglobulin (IM) Industry Trends
12.2 Human Rabies Immunoglobulin (IM) Market Drivers
12.3 Human Rabies Immunoglobulin (IM) Market Challenges
12.4 Human Rabies Immunoglobulin (IM) Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
List of Tables
Table 1. Global Human Rabies Immunoglobulin (IM) Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Global Human Rabies Immunoglobulin (IM) Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 3. Global Human Rabies Immunoglobulin (IM) Market Size by Region (US$ Million): 2024 VS 2031
Table 4. Global Human Rabies Immunoglobulin (IM) Sales by Region (2020-2025) & (K Units)
Table 5. Global Human Rabies Immunoglobulin (IM) Sales Forecast by Region (2026-2031) & (K Units)
Table 6. Global Human Rabies Immunoglobulin (IM) Revenue by Region (2020-2025) & (US$ Million)
Table 7. Global Human Rabies Immunoglobulin (IM) Revenue Forecast by Region (2026-2031) & (US$ Million)
Table 8. Global Human Rabies Immunoglobulin (IM) Sales Volume by Type (2020-2025) & (K Units)
Table 9. Global Human Rabies Immunoglobulin (IM) Sales Volume by Type (2026-2031) & (K Units)
Table 10. Global Human Rabies Immunoglobulin (IM) Revenue by Type (2020-2025) & (US$ Million)
Table 11. Global Human Rabies Immunoglobulin (IM) Revenue Forecast by Type (2026-2031) & (US$ Million)
Table 12. Global Human Rabies Immunoglobulin (IM) Sales Volume by Application (2020-2025) & (K Units)
Table 13. Global Human Rabies Immunoglobulin (IM) Sales Volume by Application (2026-2031) & (K Units)
Table 14. Global Human Rabies Immunoglobulin (IM) Revenue by Application (2020-2025) & (US$ Million)
Table 15. Global Human Rabies Immunoglobulin (IM) Revenue by Application (2026-2031) & (US$ Million)
Table 16. Global Human Rabies Immunoglobulin (IM) Sales by Manufacturer (2020-2025) & (K Units)
Table 17. Global Human Rabies Immunoglobulin (IM) Sales Share by Manufacturer (2020-2025)
Table 18. Human Rabies Immunoglobulin (IM) Revenue by Manufacturer (2020-2025) & (US$ Million)
Table 19. Human Rabies Immunoglobulin (IM) Revenue Share by Manufacturer (2020-2025)
Table 20. Key Manufacturers Human Rabies Immunoglobulin (IM) Price (2020-2025) & (US$/Unit)
Table 21. Ranking of Global Top Human Rabies Immunoglobulin (IM) Manufacturers by Revenue (US$ Million) in 2024
Table 22. Global Human Rabies Immunoglobulin (IM) Manufacturers Market Concentration Ratio (CR5 and HHI) & (2020-2025)
Table 23. Global Human Rabies Immunoglobulin (IM) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Rabies Immunoglobulin (IM) as of 2024)
Table 24. Human Rabies Immunoglobulin (IM) Manufacturers Manufacturing Base Distribution and Headquarters
Table 25. Date of International Manufacturers Enter into Human Rabies Immunoglobulin (IM) Market
Table 26. Manufacturers Human Rabies Immunoglobulin (IM) Product Type and Application
Table 27. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 28. CSL Behring Company Information
Table 29. CSL Behring Description and Business Overview
Table 30. CSL Behring Human Rabies Immunoglobulin (IM) Product
Table 31. CSL Behring Human Rabies Immunoglobulin (IM) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 32. CSL Behring Sales Proportion of Human Rabies Immunoglobulin (IM) by Product in 2024
Table 33. CSL Behring Sales Proportion of Human Rabies Immunoglobulin (IM) by Application in 2024
Table 34. CSL Behring Sales Proportion of Human Rabies Immunoglobulin (IM) by Geographic Area in 2024
Table 35. CSL Behring Recent Developments
Table 36. Grifols Company Information
Table 37. Grifols Description and Business Overview
Table 38. Grifols Human Rabies Immunoglobulin (IM) Product
Table 39. Grifols Human Rabies Immunoglobulin (IM) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 40. Grifols Sales Proportion of Human Rabies Immunoglobulin (IM) by Product in 2024
Table 41. Grifols Sales Proportion of Human Rabies Immunoglobulin (IM) by Application in 2024
Table 42. Grifols Sales Proportion of Human Rabies Immunoglobulin (IM) by Geographic Area in 2024
Table 43. Grifols Recent Developments
Table 44. Sanofi Company Information
Table 45. Sanofi Description and Business Overview
Table 46. Sanofi Human Rabies Immunoglobulin (IM) Product
Table 47. Sanofi Human Rabies Immunoglobulin (IM) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 48. Sanofi Sales Proportion of Human Rabies Immunoglobulin (IM) by Product in 2024
Table 49. Sanofi Sales Proportion of Human Rabies Immunoglobulin (IM) by Application in 2024
Table 50. Sanofi Sales Proportion of Human Rabies Immunoglobulin (IM) by Geographic Area in 2024
Table 51. Sanofi Recent Developments
Table 52. Sichuan Yuanda Shuyang Company Information
Table 53. Sichuan Yuanda Shuyang Description and Business Overview
Table 54. Sichuan Yuanda Shuyang Human Rabies Immunoglobulin (IM) Product
Table 55. Sichuan Yuanda Shuyang Human Rabies Immunoglobulin (IM) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 56. Sichuan Yuanda Shuyang Sales Proportion of Human Rabies Immunoglobulin (IM) by Product in 2024
Table 57. Sichuan Yuanda Shuyang Sales Proportion of Human Rabies Immunoglobulin (IM) by Application in 2024
Table 58. Sichuan Yuanda Shuyang Sales Proportion of Human Rabies Immunoglobulin (IM) by Geographic Area in 2024
Table 59. Sichuan Yuanda Shuyang Recent Developments
Table 60. Tiantan Bio Company Information
Table 61. Tiantan Bio Description and Business Overview
Table 62. Tiantan Bio Human Rabies Immunoglobulin (IM) Product
Table 63. Tiantan Bio Human Rabies Immunoglobulin (IM) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 64. Tiantan Bio Sales Proportion of Human Rabies Immunoglobulin (IM) by Product in 2024
Table 65. Tiantan Bio Sales Proportion of Human Rabies Immunoglobulin (IM) by Application in 2024
Table 66. Tiantan Bio Sales Proportion of Human Rabies Immunoglobulin (IM) by Geographic Area in 2024
Table 67. Tiantan Bio Recent Developments
Table 68. Kamada Company Information
Table 69. Kamada Description and Business Overview
Table 70. Kamada Human Rabies Immunoglobulin (IM) Product
Table 71. Kamada Human Rabies Immunoglobulin (IM) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 72. Kamada Sales Proportion of Human Rabies Immunoglobulin (IM) by Product in 2024
Table 73. Kamada Sales Proportion of Human Rabies Immunoglobulin (IM) by Application in 2024
Table 74. Kamada Sales Proportion of Human Rabies Immunoglobulin (IM) by Geographic Area in 2024
Table 75. Kamada Recent Developments
Table 76. CBPO Company Information
Table 77. CBPO Description and Business Overview
Table 78. CBPO Human Rabies Immunoglobulin (IM) Product
Table 79. CBPO Human Rabies Immunoglobulin (IM) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 80. CBPO Sales Proportion of Human Rabies Immunoglobulin (IM) by Product in 2024
Table 81. CBPO Sales Proportion of Human Rabies Immunoglobulin (IM) by Application in 2024
Table 82. CBPO Sales Proportion of Human Rabies Immunoglobulin (IM) by Geographic Area in 2024
Table 83. CBPO Recent Developments
Table 84. Shuanglin Bio Company Information
Table 85. Shuanglin Bio Description and Business Overview
Table 86. Shuanglin Bio Human Rabies Immunoglobulin (IM) Product
Table 87. Shuanglin Bio Human Rabies Immunoglobulin (IM) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 88. Shuanglin Bio Sales Proportion of Human Rabies Immunoglobulin (IM) by Product in 2024
Table 89. Shuanglin Bio Sales Proportion of Human Rabies Immunoglobulin (IM) by Application in 2024
Table 90. Shuanglin Bio Sales Proportion of Human Rabies Immunoglobulin (IM) by Geographic Area in 2024
Table 91. Shuanglin Bio Recent Developments
Table 92. Weiguang Bio Company Information
Table 93. Weiguang Bio Description and Business Overview
Table 94. Weiguang Bio Human Rabies Immunoglobulin (IM) Product
Table 95. Weiguang Bio Human Rabies Immunoglobulin (IM) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 96. Weiguang Bio Sales Proportion of Human Rabies Immunoglobulin (IM) by Product in 2024
Table 97. Weiguang Bio Sales Proportion of Human Rabies Immunoglobulin (IM) by Application in 2024
Table 98. Weiguang Bio Sales Proportion of Human Rabies Immunoglobulin (IM) by Geographic Area in 2024
Table 99. Weiguang Bio Recent Developments
Table 100. Shanghai RAAS Company Information
Table 101. Shanghai RAAS Description and Business Overview
Table 102. Shanghai RAAS Human Rabies Immunoglobulin (IM) Product
Table 103. Shanghai RAAS Human Rabies Immunoglobulin (IM) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 104. Shanghai RAAS Sales Proportion of Human Rabies Immunoglobulin (IM) by Product in 2024
Table 105. Shanghai RAAS Sales Proportion of Human Rabies Immunoglobulin (IM) by Application in 2024
Table 106. Shanghai RAAS Sales Proportion of Human Rabies Immunoglobulin (IM) by Geographic Area in 2024
Table 107. Shanghai RAAS Recent Developments
Table 108. Bharat Serum Company Information
Table 109. Bharat Serum Description and Business Overview
Table 110. Bharat Serum Human Rabies Immunoglobulin (IM) Product
Table 111. Bharat Serum Human Rabies Immunoglobulin (IM) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 112. Bharat Serum Sales Proportion of Human Rabies Immunoglobulin (IM) by Product in 2024
Table 113. Bharat Serum Sales Proportion of Human Rabies Immunoglobulin (IM) by Application in 2024
Table 114. Bharat Serum Sales Proportion of Human Rabies Immunoglobulin (IM) by Geographic Area in 2024
Table 115. Bharat Serum Recent Developments
Table 116. VINS Company Information
Table 117. VINS Description and Business Overview
Table 118. VINS Human Rabies Immunoglobulin (IM) Product
Table 119. VINS Human Rabies Immunoglobulin (IM) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 120. VINS Sales Proportion of Human Rabies Immunoglobulin (IM) by Product in 2024
Table 121. VINS Sales Proportion of Human Rabies Immunoglobulin (IM) by Application in 2024
Table 122. VINS Sales Proportion of Human Rabies Immunoglobulin (IM) by Geographic Area in 2024
Table 123. VINS Recent Developments
Table 124. North America Human Rabies Immunoglobulin (IM) Sales by Country (2020-2025) & (K Units)
Table 125. North America Human Rabies Immunoglobulin (IM) Sales by Country (2026-2031) & (K Units)
Table 126. North America Human Rabies Immunoglobulin (IM) Revenue by Country (2020-2025) & (US$ Million)
Table 127. North America Human Rabies Immunoglobulin (IM) Revenue by Country (2026-2031) & (US$ Million)
Table 128. North America Human Rabies Immunoglobulin (IM) Sales by Type (2020-2025) & (K Units)
Table 129. North America Human Rabies Immunoglobulin (IM) Sales by Application (2020-2025) & (K Units)
Table 130. Asia-Pacific Human Rabies Immunoglobulin (IM) Sales by Region (2020-2025) & (K Units)
Table 131. Asia-Pacific Human Rabies Immunoglobulin (IM) Sales by Region (2026-2031) & (K Units)
Table 132. Asia-Pacific Human Rabies Immunoglobulin (IM) Revenue by Region (2020-2025) & (US$ Million)
Table 133. Asia-Pacific Human Rabies Immunoglobulin (IM) Revenue by Region (2026-2031) & (US$ Million)
Table 134. Asia-Pacific Human Rabies Immunoglobulin (IM) Sales by Type (2020-2025) & (K Units)
Table 135. Asia-Pacific Human Rabies Immunoglobulin (IM) Sales by Application (2020-2025) & (K Units)
Table 136. Europe Human Rabies Immunoglobulin (IM) Sales by Country (2020-2025) & (K Units)
Table 137. Europe Human Rabies Immunoglobulin (IM) Sales by Country (2026-2031) & (K Units)
Table 138. Europe Human Rabies Immunoglobulin (IM) Revenue by Country (2020-2025) & (US$ Million)
Table 139. Europe Human Rabies Immunoglobulin (IM) Revenue by Country (2026-2031) & (US$ Million)
Table 140. Europe Human Rabies Immunoglobulin (IM) Sales by Type (2020-2025) & (K Units)
Table 141. Europe Human Rabies Immunoglobulin (IM) Sales by Application (2020-2025) & (K Units)
Table 142. Latin America Human Rabies Immunoglobulin (IM) Sales by Country (2020-2025) & (K Units)
Table 143. Latin America Human Rabies Immunoglobulin (IM) Sales by Country (2026-2031) & (K Units)
Table 144. Latin America Human Rabies Immunoglobulin (IM) Revenue by Country (2020-2025) & (US$ Million)
Table 145. Latin America Human Rabies Immunoglobulin (IM) Revenue by Country (2026-2031) & (US$ Million)
Table 146. Latin America Human Rabies Immunoglobulin (IM) Sales by Type (2020-2025) & (K Units)
Table 147. Latin America Human Rabies Immunoglobulin (IM) Sales by Application (2020-2025) & (K Units)
Table 148. Middle East and Africa Human Rabies Immunoglobulin (IM) Sales by Country (2020-2025) & (K Units)
Table 149. Middle East and Africa Human Rabies Immunoglobulin (IM) Sales by Country (2026-2031) & (K Units)
Table 150. Middle East and Africa Human Rabies Immunoglobulin (IM) Revenue by Country (2020-2025) & (US$ Million)
Table 151. Middle East and Africa Human Rabies Immunoglobulin (IM) Revenue by Country (2026-2031) & (US$ Million)
Table 152. Middle East and Africa Human Rabies Immunoglobulin (IM) Sales by Type (2020-2025) & (K Units)
Table 153. Middle East and Africa Human Rabies Immunoglobulin (IM) Sales by Application (2020-2025) & (K Units)
Table 154. Human Rabies Immunoglobulin (IM) Key Raw Materials, Industry Status and Trend
Table 155. Human Rabies Immunoglobulin (IM) Key Raw Materials and Upstream Suppliers
Table 156. Human Rabies Immunoglobulin (IM) Clients Status and Trend
Table 157. Human Rabies Immunoglobulin (IM) Typical Clients
Table 158. Human Rabies Immunoglobulin (IM) Distributors
Table 159. Human Rabies Immunoglobulin (IM) Market Trends
Table 160. Human Rabies Immunoglobulin (IM) Market Drivers
Table 161. Human Rabies Immunoglobulin (IM) Market Challenges
Table 162. Human Rabies Immunoglobulin (IM) Market Restraints
Table 163. Research Programs/Design for This Report
Table 164. Key Data Information from Secondary Sources
Table 165. Key Data Information from Primary Sources
Table 166. QYR Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. Human Rabies Immunoglobulin (IM) Product Picture
Figure 2. Global Human Rabies Immunoglobulin (IM) Market Size by Type (US$ Million): 2020 VS 2024 VS 2031
Figure 3. Global Human Rabies Immunoglobulin (IM) Sales Market Share by Type in 2024 & 2031
Figure 4. ERIG Product Picture
Figure 5. HRIG Product Picture
Figure 6. Global Human Rabies Immunoglobulin (IM) Market Size by Application (US$ Million): 2020 VS 2024 VS 2031
Figure 7. Global Human Rabies Immunoglobulin (IM) Sales Market Share by Application in 2024 & 2031
Figure 8. Category II Exposure
Figure 9. Category III Exposure
Figure 10. Human Rabies Immunoglobulin (IM) Report Years Considered
Figure 11. Global Human Rabies Immunoglobulin (IM) Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 12. Global Human Rabies Immunoglobulin (IM) Market Size 2020-2031 (US$ Million)
Figure 13. Global Human Rabies Immunoglobulin (IM) Sales 2020-2031 (K Units)
Figure 14. Global Human Rabies Immunoglobulin (IM) Sales Market Share Forecast by Region (2020-2031)
Figure 15. Global Human Rabies Immunoglobulin (IM) Revenue Market Share by Region (2020-2031)
Figure 16. Global Human Rabies Immunoglobulin (IM) Sales Market Share Forecast by Type (2020-2031)
Figure 17. Global Human Rabies Immunoglobulin (IM) Revenue Market Share Forecast by Type (2020-2031)
Figure 18. Human Rabies Immunoglobulin (IM) Average Selling Price (ASP) by Type (2020-2025) & (US$/Unit)
Figure 19. Global Human Rabies Immunoglobulin (IM) Sales Market Share Forecast by Application (2020-2031)
Figure 20. Global Human Rabies Immunoglobulin (IM) Revenue Market Share Forecast by Application (2020-2031)
Figure 21. Human Rabies Immunoglobulin (IM) Average Selling Price (ASP) by Application (2020-2025) & (US$/Unit)
Figure 22. ERIG of Human Rabies Immunoglobulin (IM) Revenue Market Share by Application, 2024 VS 2031
Figure 23. HRIG of Human Rabies Immunoglobulin (IM) Revenue Market Share by Application, 2024 VS 2031
Figure 24. Global Human Rabies Immunoglobulin (IM) Sales Share by Manufacturer in 2024
Figure 25. Human Rabies Immunoglobulin (IM) Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 26. ERIG Market Sales Proportion by Manufacturer in 2024
Figure 27. HRIG Market Sales Proportion by Manufacturer in 2024
Figure 28. North America Human Rabies Immunoglobulin (IM) Revenue 2020-2031 (US$ Million)
Figure 29. North America Human Rabies Immunoglobulin (IM) Sales Market Share by Type (2020-2025)
Figure 30. North America Human Rabies Immunoglobulin (IM) Sales Market Share by Application (2020-2025)
Figure 31. Asia-Pacific Human Rabies Immunoglobulin (IM) Revenue 2020-2031 (US$ Million)
Figure 32. Asia-Pacific Human Rabies Immunoglobulin (IM) Sales Market Share by Region (2020-2031)
Figure 33. Asia-Pacific Human Rabies Immunoglobulin (IM) Revenue Market Share by Region (2020-2031)
Figure 34. Asia-Pacific Human Rabies Immunoglobulin (IM) Sales Market Share by Type (2020-2025)
Figure 35. Asia-Pacific Human Rabies Immunoglobulin (IM) Sales Market Share by Application (2020-2025)
Figure 36. Europe Human Rabies Immunoglobulin (IM) Revenue Growth Rate 2020-2031 (US$ Million)
Figure 37. Europe Human Rabies Immunoglobulin (IM) Sales Market Share by Country (2020-2031)
Figure 38. Europe Human Rabies Immunoglobulin (IM) Revenue Market Share by Country (2020-2031)
Figure 39. Europe Human Rabies Immunoglobulin (IM) Sales Market Share by Type (2020-2025)
Figure 40. Europe Human Rabies Immunoglobulin (IM) Sales Market Share by Application (2020-2025)
Figure 41. Latin America Human Rabies Immunoglobulin (IM) Revenue Growth Rate 2020-2031 (US$ Million)
Figure 42. Latin America Human Rabies Immunoglobulin (IM) Sales Market Share by Country (2020-2031)
Figure 43. Latin America Human Rabies Immunoglobulin (IM) Revenue Market Share by Country (2020-2025)
Figure 44. Latin America Human Rabies Immunoglobulin (IM) Sales Market Share by Type (2020-2025)
Figure 45. Latin America Human Rabies Immunoglobulin (IM) Sales Market Share by Application (2020-2025)
Figure 46. Middle East and Africa Human Rabies Immunoglobulin (IM) Revenue Growth Rate 2020-2031 (US$ Million)
Figure 47. Middle East and Africa Human Rabies Immunoglobulin (IM) Sales Market Share by Country (2020-2031)
Figure 48. Middle East and Africa Human Rabies Immunoglobulin (IM) Revenue Market Share by Country (2020-2031)
Figure 49. Middle East and Africa Human Rabies Immunoglobulin (IM) Sales Market Share by Type (2020-2025)
Figure 50. Middle East and Africa Human Rabies Immunoglobulin (IM) Sales Market Share by Application (2020-2025)
Figure 51. Human Rabies Immunoglobulin (IM) Supply Chain (Upstream and Downstream Market)
Figure 52. Global Production Market Share of Human Rabies Immunoglobulin (IM) Raw Materials by Region in 2024
Figure 53. Human Rabies Immunoglobulin (IM) Distribution Channels
Figure 54. Global Human Rabies Immunoglobulin (IM) Percentage 2020-2031: Indirect Sales VS Direct Sales
Figure 55. Global Human Rabies Immunoglobulin (IM) Percentage 2020-2031: Online Sales VS Offline Sales
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed
Table 1. Global Human Rabies Immunoglobulin (IM) Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Global Human Rabies Immunoglobulin (IM) Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 3. Global Human Rabies Immunoglobulin (IM) Market Size by Region (US$ Million): 2024 VS 2031
Table 4. Global Human Rabies Immunoglobulin (IM) Sales by Region (2020-2025) & (K Units)
Table 5. Global Human Rabies Immunoglobulin (IM) Sales Forecast by Region (2026-2031) & (K Units)
Table 6. Global Human Rabies Immunoglobulin (IM) Revenue by Region (2020-2025) & (US$ Million)
Table 7. Global Human Rabies Immunoglobulin (IM) Revenue Forecast by Region (2026-2031) & (US$ Million)
Table 8. Global Human Rabies Immunoglobulin (IM) Sales Volume by Type (2020-2025) & (K Units)
Table 9. Global Human Rabies Immunoglobulin (IM) Sales Volume by Type (2026-2031) & (K Units)
Table 10. Global Human Rabies Immunoglobulin (IM) Revenue by Type (2020-2025) & (US$ Million)
Table 11. Global Human Rabies Immunoglobulin (IM) Revenue Forecast by Type (2026-2031) & (US$ Million)
Table 12. Global Human Rabies Immunoglobulin (IM) Sales Volume by Application (2020-2025) & (K Units)
Table 13. Global Human Rabies Immunoglobulin (IM) Sales Volume by Application (2026-2031) & (K Units)
Table 14. Global Human Rabies Immunoglobulin (IM) Revenue by Application (2020-2025) & (US$ Million)
Table 15. Global Human Rabies Immunoglobulin (IM) Revenue by Application (2026-2031) & (US$ Million)
Table 16. Global Human Rabies Immunoglobulin (IM) Sales by Manufacturer (2020-2025) & (K Units)
Table 17. Global Human Rabies Immunoglobulin (IM) Sales Share by Manufacturer (2020-2025)
Table 18. Human Rabies Immunoglobulin (IM) Revenue by Manufacturer (2020-2025) & (US$ Million)
Table 19. Human Rabies Immunoglobulin (IM) Revenue Share by Manufacturer (2020-2025)
Table 20. Key Manufacturers Human Rabies Immunoglobulin (IM) Price (2020-2025) & (US$/Unit)
Table 21. Ranking of Global Top Human Rabies Immunoglobulin (IM) Manufacturers by Revenue (US$ Million) in 2024
Table 22. Global Human Rabies Immunoglobulin (IM) Manufacturers Market Concentration Ratio (CR5 and HHI) & (2020-2025)
Table 23. Global Human Rabies Immunoglobulin (IM) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Rabies Immunoglobulin (IM) as of 2024)
Table 24. Human Rabies Immunoglobulin (IM) Manufacturers Manufacturing Base Distribution and Headquarters
Table 25. Date of International Manufacturers Enter into Human Rabies Immunoglobulin (IM) Market
Table 26. Manufacturers Human Rabies Immunoglobulin (IM) Product Type and Application
Table 27. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 28. CSL Behring Company Information
Table 29. CSL Behring Description and Business Overview
Table 30. CSL Behring Human Rabies Immunoglobulin (IM) Product
Table 31. CSL Behring Human Rabies Immunoglobulin (IM) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 32. CSL Behring Sales Proportion of Human Rabies Immunoglobulin (IM) by Product in 2024
Table 33. CSL Behring Sales Proportion of Human Rabies Immunoglobulin (IM) by Application in 2024
Table 34. CSL Behring Sales Proportion of Human Rabies Immunoglobulin (IM) by Geographic Area in 2024
Table 35. CSL Behring Recent Developments
Table 36. Grifols Company Information
Table 37. Grifols Description and Business Overview
Table 38. Grifols Human Rabies Immunoglobulin (IM) Product
Table 39. Grifols Human Rabies Immunoglobulin (IM) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 40. Grifols Sales Proportion of Human Rabies Immunoglobulin (IM) by Product in 2024
Table 41. Grifols Sales Proportion of Human Rabies Immunoglobulin (IM) by Application in 2024
Table 42. Grifols Sales Proportion of Human Rabies Immunoglobulin (IM) by Geographic Area in 2024
Table 43. Grifols Recent Developments
Table 44. Sanofi Company Information
Table 45. Sanofi Description and Business Overview
Table 46. Sanofi Human Rabies Immunoglobulin (IM) Product
Table 47. Sanofi Human Rabies Immunoglobulin (IM) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 48. Sanofi Sales Proportion of Human Rabies Immunoglobulin (IM) by Product in 2024
Table 49. Sanofi Sales Proportion of Human Rabies Immunoglobulin (IM) by Application in 2024
Table 50. Sanofi Sales Proportion of Human Rabies Immunoglobulin (IM) by Geographic Area in 2024
Table 51. Sanofi Recent Developments
Table 52. Sichuan Yuanda Shuyang Company Information
Table 53. Sichuan Yuanda Shuyang Description and Business Overview
Table 54. Sichuan Yuanda Shuyang Human Rabies Immunoglobulin (IM) Product
Table 55. Sichuan Yuanda Shuyang Human Rabies Immunoglobulin (IM) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 56. Sichuan Yuanda Shuyang Sales Proportion of Human Rabies Immunoglobulin (IM) by Product in 2024
Table 57. Sichuan Yuanda Shuyang Sales Proportion of Human Rabies Immunoglobulin (IM) by Application in 2024
Table 58. Sichuan Yuanda Shuyang Sales Proportion of Human Rabies Immunoglobulin (IM) by Geographic Area in 2024
Table 59. Sichuan Yuanda Shuyang Recent Developments
Table 60. Tiantan Bio Company Information
Table 61. Tiantan Bio Description and Business Overview
Table 62. Tiantan Bio Human Rabies Immunoglobulin (IM) Product
Table 63. Tiantan Bio Human Rabies Immunoglobulin (IM) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 64. Tiantan Bio Sales Proportion of Human Rabies Immunoglobulin (IM) by Product in 2024
Table 65. Tiantan Bio Sales Proportion of Human Rabies Immunoglobulin (IM) by Application in 2024
Table 66. Tiantan Bio Sales Proportion of Human Rabies Immunoglobulin (IM) by Geographic Area in 2024
Table 67. Tiantan Bio Recent Developments
Table 68. Kamada Company Information
Table 69. Kamada Description and Business Overview
Table 70. Kamada Human Rabies Immunoglobulin (IM) Product
Table 71. Kamada Human Rabies Immunoglobulin (IM) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 72. Kamada Sales Proportion of Human Rabies Immunoglobulin (IM) by Product in 2024
Table 73. Kamada Sales Proportion of Human Rabies Immunoglobulin (IM) by Application in 2024
Table 74. Kamada Sales Proportion of Human Rabies Immunoglobulin (IM) by Geographic Area in 2024
Table 75. Kamada Recent Developments
Table 76. CBPO Company Information
Table 77. CBPO Description and Business Overview
Table 78. CBPO Human Rabies Immunoglobulin (IM) Product
Table 79. CBPO Human Rabies Immunoglobulin (IM) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 80. CBPO Sales Proportion of Human Rabies Immunoglobulin (IM) by Product in 2024
Table 81. CBPO Sales Proportion of Human Rabies Immunoglobulin (IM) by Application in 2024
Table 82. CBPO Sales Proportion of Human Rabies Immunoglobulin (IM) by Geographic Area in 2024
Table 83. CBPO Recent Developments
Table 84. Shuanglin Bio Company Information
Table 85. Shuanglin Bio Description and Business Overview
Table 86. Shuanglin Bio Human Rabies Immunoglobulin (IM) Product
Table 87. Shuanglin Bio Human Rabies Immunoglobulin (IM) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 88. Shuanglin Bio Sales Proportion of Human Rabies Immunoglobulin (IM) by Product in 2024
Table 89. Shuanglin Bio Sales Proportion of Human Rabies Immunoglobulin (IM) by Application in 2024
Table 90. Shuanglin Bio Sales Proportion of Human Rabies Immunoglobulin (IM) by Geographic Area in 2024
Table 91. Shuanglin Bio Recent Developments
Table 92. Weiguang Bio Company Information
Table 93. Weiguang Bio Description and Business Overview
Table 94. Weiguang Bio Human Rabies Immunoglobulin (IM) Product
Table 95. Weiguang Bio Human Rabies Immunoglobulin (IM) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 96. Weiguang Bio Sales Proportion of Human Rabies Immunoglobulin (IM) by Product in 2024
Table 97. Weiguang Bio Sales Proportion of Human Rabies Immunoglobulin (IM) by Application in 2024
Table 98. Weiguang Bio Sales Proportion of Human Rabies Immunoglobulin (IM) by Geographic Area in 2024
Table 99. Weiguang Bio Recent Developments
Table 100. Shanghai RAAS Company Information
Table 101. Shanghai RAAS Description and Business Overview
Table 102. Shanghai RAAS Human Rabies Immunoglobulin (IM) Product
Table 103. Shanghai RAAS Human Rabies Immunoglobulin (IM) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 104. Shanghai RAAS Sales Proportion of Human Rabies Immunoglobulin (IM) by Product in 2024
Table 105. Shanghai RAAS Sales Proportion of Human Rabies Immunoglobulin (IM) by Application in 2024
Table 106. Shanghai RAAS Sales Proportion of Human Rabies Immunoglobulin (IM) by Geographic Area in 2024
Table 107. Shanghai RAAS Recent Developments
Table 108. Bharat Serum Company Information
Table 109. Bharat Serum Description and Business Overview
Table 110. Bharat Serum Human Rabies Immunoglobulin (IM) Product
Table 111. Bharat Serum Human Rabies Immunoglobulin (IM) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 112. Bharat Serum Sales Proportion of Human Rabies Immunoglobulin (IM) by Product in 2024
Table 113. Bharat Serum Sales Proportion of Human Rabies Immunoglobulin (IM) by Application in 2024
Table 114. Bharat Serum Sales Proportion of Human Rabies Immunoglobulin (IM) by Geographic Area in 2024
Table 115. Bharat Serum Recent Developments
Table 116. VINS Company Information
Table 117. VINS Description and Business Overview
Table 118. VINS Human Rabies Immunoglobulin (IM) Product
Table 119. VINS Human Rabies Immunoglobulin (IM) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 120. VINS Sales Proportion of Human Rabies Immunoglobulin (IM) by Product in 2024
Table 121. VINS Sales Proportion of Human Rabies Immunoglobulin (IM) by Application in 2024
Table 122. VINS Sales Proportion of Human Rabies Immunoglobulin (IM) by Geographic Area in 2024
Table 123. VINS Recent Developments
Table 124. North America Human Rabies Immunoglobulin (IM) Sales by Country (2020-2025) & (K Units)
Table 125. North America Human Rabies Immunoglobulin (IM) Sales by Country (2026-2031) & (K Units)
Table 126. North America Human Rabies Immunoglobulin (IM) Revenue by Country (2020-2025) & (US$ Million)
Table 127. North America Human Rabies Immunoglobulin (IM) Revenue by Country (2026-2031) & (US$ Million)
Table 128. North America Human Rabies Immunoglobulin (IM) Sales by Type (2020-2025) & (K Units)
Table 129. North America Human Rabies Immunoglobulin (IM) Sales by Application (2020-2025) & (K Units)
Table 130. Asia-Pacific Human Rabies Immunoglobulin (IM) Sales by Region (2020-2025) & (K Units)
Table 131. Asia-Pacific Human Rabies Immunoglobulin (IM) Sales by Region (2026-2031) & (K Units)
Table 132. Asia-Pacific Human Rabies Immunoglobulin (IM) Revenue by Region (2020-2025) & (US$ Million)
Table 133. Asia-Pacific Human Rabies Immunoglobulin (IM) Revenue by Region (2026-2031) & (US$ Million)
Table 134. Asia-Pacific Human Rabies Immunoglobulin (IM) Sales by Type (2020-2025) & (K Units)
Table 135. Asia-Pacific Human Rabies Immunoglobulin (IM) Sales by Application (2020-2025) & (K Units)
Table 136. Europe Human Rabies Immunoglobulin (IM) Sales by Country (2020-2025) & (K Units)
Table 137. Europe Human Rabies Immunoglobulin (IM) Sales by Country (2026-2031) & (K Units)
Table 138. Europe Human Rabies Immunoglobulin (IM) Revenue by Country (2020-2025) & (US$ Million)
Table 139. Europe Human Rabies Immunoglobulin (IM) Revenue by Country (2026-2031) & (US$ Million)
Table 140. Europe Human Rabies Immunoglobulin (IM) Sales by Type (2020-2025) & (K Units)
Table 141. Europe Human Rabies Immunoglobulin (IM) Sales by Application (2020-2025) & (K Units)
Table 142. Latin America Human Rabies Immunoglobulin (IM) Sales by Country (2020-2025) & (K Units)
Table 143. Latin America Human Rabies Immunoglobulin (IM) Sales by Country (2026-2031) & (K Units)
Table 144. Latin America Human Rabies Immunoglobulin (IM) Revenue by Country (2020-2025) & (US$ Million)
Table 145. Latin America Human Rabies Immunoglobulin (IM) Revenue by Country (2026-2031) & (US$ Million)
Table 146. Latin America Human Rabies Immunoglobulin (IM) Sales by Type (2020-2025) & (K Units)
Table 147. Latin America Human Rabies Immunoglobulin (IM) Sales by Application (2020-2025) & (K Units)
Table 148. Middle East and Africa Human Rabies Immunoglobulin (IM) Sales by Country (2020-2025) & (K Units)
Table 149. Middle East and Africa Human Rabies Immunoglobulin (IM) Sales by Country (2026-2031) & (K Units)
Table 150. Middle East and Africa Human Rabies Immunoglobulin (IM) Revenue by Country (2020-2025) & (US$ Million)
Table 151. Middle East and Africa Human Rabies Immunoglobulin (IM) Revenue by Country (2026-2031) & (US$ Million)
Table 152. Middle East and Africa Human Rabies Immunoglobulin (IM) Sales by Type (2020-2025) & (K Units)
Table 153. Middle East and Africa Human Rabies Immunoglobulin (IM) Sales by Application (2020-2025) & (K Units)
Table 154. Human Rabies Immunoglobulin (IM) Key Raw Materials, Industry Status and Trend
Table 155. Human Rabies Immunoglobulin (IM) Key Raw Materials and Upstream Suppliers
Table 156. Human Rabies Immunoglobulin (IM) Clients Status and Trend
Table 157. Human Rabies Immunoglobulin (IM) Typical Clients
Table 158. Human Rabies Immunoglobulin (IM) Distributors
Table 159. Human Rabies Immunoglobulin (IM) Market Trends
Table 160. Human Rabies Immunoglobulin (IM) Market Drivers
Table 161. Human Rabies Immunoglobulin (IM) Market Challenges
Table 162. Human Rabies Immunoglobulin (IM) Market Restraints
Table 163. Research Programs/Design for This Report
Table 164. Key Data Information from Secondary Sources
Table 165. Key Data Information from Primary Sources
Table 166. QYR Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. Human Rabies Immunoglobulin (IM) Product Picture
Figure 2. Global Human Rabies Immunoglobulin (IM) Market Size by Type (US$ Million): 2020 VS 2024 VS 2031
Figure 3. Global Human Rabies Immunoglobulin (IM) Sales Market Share by Type in 2024 & 2031
Figure 4. ERIG Product Picture
Figure 5. HRIG Product Picture
Figure 6. Global Human Rabies Immunoglobulin (IM) Market Size by Application (US$ Million): 2020 VS 2024 VS 2031
Figure 7. Global Human Rabies Immunoglobulin (IM) Sales Market Share by Application in 2024 & 2031
Figure 8. Category II Exposure
Figure 9. Category III Exposure
Figure 10. Human Rabies Immunoglobulin (IM) Report Years Considered
Figure 11. Global Human Rabies Immunoglobulin (IM) Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 12. Global Human Rabies Immunoglobulin (IM) Market Size 2020-2031 (US$ Million)
Figure 13. Global Human Rabies Immunoglobulin (IM) Sales 2020-2031 (K Units)
Figure 14. Global Human Rabies Immunoglobulin (IM) Sales Market Share Forecast by Region (2020-2031)
Figure 15. Global Human Rabies Immunoglobulin (IM) Revenue Market Share by Region (2020-2031)
Figure 16. Global Human Rabies Immunoglobulin (IM) Sales Market Share Forecast by Type (2020-2031)
Figure 17. Global Human Rabies Immunoglobulin (IM) Revenue Market Share Forecast by Type (2020-2031)
Figure 18. Human Rabies Immunoglobulin (IM) Average Selling Price (ASP) by Type (2020-2025) & (US$/Unit)
Figure 19. Global Human Rabies Immunoglobulin (IM) Sales Market Share Forecast by Application (2020-2031)
Figure 20. Global Human Rabies Immunoglobulin (IM) Revenue Market Share Forecast by Application (2020-2031)
Figure 21. Human Rabies Immunoglobulin (IM) Average Selling Price (ASP) by Application (2020-2025) & (US$/Unit)
Figure 22. ERIG of Human Rabies Immunoglobulin (IM) Revenue Market Share by Application, 2024 VS 2031
Figure 23. HRIG of Human Rabies Immunoglobulin (IM) Revenue Market Share by Application, 2024 VS 2031
Figure 24. Global Human Rabies Immunoglobulin (IM) Sales Share by Manufacturer in 2024
Figure 25. Human Rabies Immunoglobulin (IM) Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 26. ERIG Market Sales Proportion by Manufacturer in 2024
Figure 27. HRIG Market Sales Proportion by Manufacturer in 2024
Figure 28. North America Human Rabies Immunoglobulin (IM) Revenue 2020-2031 (US$ Million)
Figure 29. North America Human Rabies Immunoglobulin (IM) Sales Market Share by Type (2020-2025)
Figure 30. North America Human Rabies Immunoglobulin (IM) Sales Market Share by Application (2020-2025)
Figure 31. Asia-Pacific Human Rabies Immunoglobulin (IM) Revenue 2020-2031 (US$ Million)
Figure 32. Asia-Pacific Human Rabies Immunoglobulin (IM) Sales Market Share by Region (2020-2031)
Figure 33. Asia-Pacific Human Rabies Immunoglobulin (IM) Revenue Market Share by Region (2020-2031)
Figure 34. Asia-Pacific Human Rabies Immunoglobulin (IM) Sales Market Share by Type (2020-2025)
Figure 35. Asia-Pacific Human Rabies Immunoglobulin (IM) Sales Market Share by Application (2020-2025)
Figure 36. Europe Human Rabies Immunoglobulin (IM) Revenue Growth Rate 2020-2031 (US$ Million)
Figure 37. Europe Human Rabies Immunoglobulin (IM) Sales Market Share by Country (2020-2031)
Figure 38. Europe Human Rabies Immunoglobulin (IM) Revenue Market Share by Country (2020-2031)
Figure 39. Europe Human Rabies Immunoglobulin (IM) Sales Market Share by Type (2020-2025)
Figure 40. Europe Human Rabies Immunoglobulin (IM) Sales Market Share by Application (2020-2025)
Figure 41. Latin America Human Rabies Immunoglobulin (IM) Revenue Growth Rate 2020-2031 (US$ Million)
Figure 42. Latin America Human Rabies Immunoglobulin (IM) Sales Market Share by Country (2020-2031)
Figure 43. Latin America Human Rabies Immunoglobulin (IM) Revenue Market Share by Country (2020-2025)
Figure 44. Latin America Human Rabies Immunoglobulin (IM) Sales Market Share by Type (2020-2025)
Figure 45. Latin America Human Rabies Immunoglobulin (IM) Sales Market Share by Application (2020-2025)
Figure 46. Middle East and Africa Human Rabies Immunoglobulin (IM) Revenue Growth Rate 2020-2031 (US$ Million)
Figure 47. Middle East and Africa Human Rabies Immunoglobulin (IM) Sales Market Share by Country (2020-2031)
Figure 48. Middle East and Africa Human Rabies Immunoglobulin (IM) Revenue Market Share by Country (2020-2031)
Figure 49. Middle East and Africa Human Rabies Immunoglobulin (IM) Sales Market Share by Type (2020-2025)
Figure 50. Middle East and Africa Human Rabies Immunoglobulin (IM) Sales Market Share by Application (2020-2025)
Figure 51. Human Rabies Immunoglobulin (IM) Supply Chain (Upstream and Downstream Market)
Figure 52. Global Production Market Share of Human Rabies Immunoglobulin (IM) Raw Materials by Region in 2024
Figure 53. Human Rabies Immunoglobulin (IM) Distribution Channels
Figure 54. Global Human Rabies Immunoglobulin (IM) Percentage 2020-2031: Indirect Sales VS Direct Sales
Figure 55. Global Human Rabies Immunoglobulin (IM) Percentage 2020-2031: Online Sales VS Offline Sales
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Medical Waste Fluid Solidifier Market Research Report 2025
Jun 12, 25
Global Metalized Bubble Material Market Research Report 2025
Jun 12, 25
Global 70% Isopropyl Rubbing Alcohol Market Research Report 2025
Jun 12, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232